Dandan Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dandan Peng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Aaron Karlsberg
Department of Clinical Pharmacy, School of Pharmacy, University of Southern California
1 shared publication- Amanda M. Burkhardt
Department of Clinical Pharmacy, School of Pharmacy, University of Southern California
1 shared publication - Anish Nagareddy
Viterbi School of Engineering, University of Southern California
1 shared publication - Antoni Ribas
Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA
1 shared publication - Ben Weisburd
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
1 shared publication - Bida Gu
Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
A population-scale map of human tandem repeat composition and mutation dynamics from long-read assemblies
Tandem repeats (TRs) are highly mutable genomic elements composed of repeated motifs that drive genetic diversity and contribute to disease. Due to limited resolution at population scale, their mutation dynamics are incompletely understood. Here, we present TRCompDB, a reference database constructed on 832 human genomes that annotates the compositional diversity and population structure for 4.4 million TR loci. Leveraging SNP-based genealogical trees, we estimated locus-specific mutation rates for 4,037,274 TRs, revealing mutation rates ranging from 10 −10 to 10 −3 on TRCompDB loci. In addition to TR length and coding potential, mutation rate was influenced by recombination and the wider duplication context. Moreover, a subset of AT-rich pentanucleotide repeats including loci linked to Familial Myoclonic Adult Epilepsy and spinocerebellar ataxia showed extreme mutation rates. Beyond single-motif changes, 29,964 loci exhibited higher-order duplication patterns that increased allelic complexity, among which 3,351 VNTRs showed evolutionary recurrence. These results establish TRCompDB as a resource for studying global patterns of tandem repeat evolution and their contribution to human disease.
Open AccessA population-scale map of human tandem repeat composition and mutation dynamics from long-read assemblies
Tandem repeats (TRs) are highly mutable genomic elements composed of repeated motifs that drive genetic diversity and contribute to disease. Due to limited resolution at population scale, their mutation dynamics are incompletely understood. Here, we present TRCompDB, a reference database constructed on 832 human genomes that annotates the compositional diversity and population structure for 4.4 million TR loci. Leveraging SNP-based genealogical trees, we estimated locus-specific mutation rates for 4,037,274 TRs, revealing mutation rates ranging from 10 −10 to 10 −3 on TRCompDB loci. In addition to TR length and coding potential, mutation rate was influenced by recombination and the wider duplication context. Moreover, a subset of AT-rich pentanucleotide repeats including loci linked to Familial Myoclonic Adult Epilepsy and spinocerebellar ataxia showed extreme mutation rates. Beyond single-motif changes, 29,964 loci exhibited higher-order duplication patterns that increased allelic complexity, among which 3,351 VNTRs showed evolutionary recurrence. These results establish TRCompDB as a resource for studying global patterns of tandem repeat evolution and their contribution to human disease.
- Open Access
Evaluating ARG-estimation methods in the context of estimating population-mean polygenic score histories
Scalable methods for estimating marginal coalescent trees across the genome present new opportunities for studying evolution and have generated considerable excitement, with new methods extending scalability to thousands of samples. Benchmarking of the available methods has revealed general tradeoffs between accuracy and scalability, but performance in downstream applications has not always been easily predictable from general performance measures, suggesting that specific features of the ARG may be important for specific downstream applications of estimated ARGs. To exemplify this point, we benchmark ARG estimation methods with respect to a specific set of methods for estimating the historical time course of a population-mean polygenic score (PGS) using the marginal coalescent trees encoded by the ancestral recombination graph (ARG). Here we examine the performance in simulation of seven ARG estimation methods: ARGweaver, RENT+, Relate, tsinfer+tsdate, ARG-Needle, ASMC-clust , and SINGER , using their estimated coalescent trees and examining bias, mean squared error (MSE), confidence interval coverage, and Type I and II error rates of the downstream methods. Although it does not scale to the sample sizes attainable by other new methods, SINGER produced the most accurate estimated PGS histories in many instances, even when Relate, tsinfer+tsdate, ARG-Needle and ASMC-clust used samples ten or more times as large as those used by SINGER . In general, the best choice of method depends on the number of samples available and the historical time period of interest. In particular, the unprecedented sample sizes allowed by Relate, tsinfer+tsdate, ARG-Needle , and ASMC-clust are of greatest importance when the recent past is of interest—further back in time, most of the tree has coalesced, and differences in contemporary sample size are less salient.
Open AccessEvaluating ARG-estimation methods in the context of estimating population-mean polygenic score histories
Scalable methods for estimating marginal coalescent trees across the genome present new opportunities for studying evolution and have generated considerable excitement, with new methods extending scalability to thousands of samples. Benchmarking of the available methods has revealed general tradeoffs between accuracy and scalability, but performance in downstream applications has not always been easily predictable from general performance measures, suggesting that specific features of the ARG may be important for specific downstream applications of estimated ARGs. To exemplify this point, we benchmark ARG estimation methods with respect to a specific set of methods for estimating the historical time course of a population-mean polygenic score (PGS) using the marginal coalescent trees encoded by the ancestral recombination graph (ARG). Here we examine the performance in simulation of seven ARG estimation methods: ARGweaver, RENT+, Relate, tsinfer+tsdate, ARG-Needle, ASMC-clust , and SINGER , using their estimated coalescent trees and examining bias, mean squared error (MSE), confidence interval coverage, and Type I and II error rates of the downstream methods. Although it does not scale to the sample sizes attainable by other new methods, SINGER produced the most accurate estimated PGS histories in many instances, even when Relate, tsinfer+tsdate, ARG-Needle and ASMC-clust used samples ten or more times as large as those used by SINGER . In general, the best choice of method depends on the number of samples available and the historical time period of interest. In particular, the unprecedented sample sizes allowed by Relate, tsinfer+tsdate, ARG-Needle , and ASMC-clust are of greatest importance when the recent past is of interest—further back in time, most of the tree has coalesced, and differences in contemporary sample size are less salient.
- Open Access
Rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing
The ability to identify and track T cell receptor (TCR) sequences from patient samples is becoming central to the field of cancer research and immunotherapy. Tracking genetically engineered T cells expressing TCRs that target specific tumor antigens is important to determine the persistence of these cells and quantify tumor responses. The available high-throughput method to profile T cell receptor repertoires is generally referred to as TCR sequencing (TCR-Seq). However, the available TCR-Seq data is limited compared to RNA sequencing (RNA-Seq). In this paper, we have benchmarked the ability of RNA-Seq-based methods to profile TCR repertoires by examining 19 bulk RNA-Seq samples across four cancer cohorts including both T cell rich and poor tissue types. We have performed a comprehensive evaluation of the existing RNA-Seq-based repertoire profiling methods using targeted TCR-Seq as the gold standard. We also highlighted scenarios under which the RNA-Seq approach is suitable and can provide comparable accuracy to the TCR-Seq approach. Our results show that RNA-Seq-based methods are able to effectively capture the clonotypes and estimate the diversity of TCR repertoires, as well as to provide relative frequencies of clonotypes in T cell rich tissues and monoclonal repertoires. However, RNA-Seq-based TCR profiling methods have limited power in T cell poor tissues, especially in polyclonal repertoires of T cell poor tissues. The results of our benchmarking provide an additional appealing argument to incorporate the RNA-Seq into immune repertoire screening of cancer patients as it offers broader knowledge into the transcriptomic changes that exceed the limited information provided by TCR-Seq.
Open AccessRigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing
The ability to identify and track T cell receptor (TCR) sequences from patient samples is becoming central to the field of cancer research and immunotherapy. Tracking genetically engineered T cells expressing TCRs that target specific tumor antigens is important to determine the persistence of these cells and quantify tumor responses. The available high-throughput method to profile T cell receptor repertoires is generally referred to as TCR sequencing (TCR-Seq). However, the available TCR-Seq data is limited compared to RNA sequencing (RNA-Seq). In this paper, we have benchmarked the ability of RNA-Seq-based methods to profile TCR repertoires by examining 19 bulk RNA-Seq samples across four cancer cohorts including both T cell rich and poor tissue types. We have performed a comprehensive evaluation of the existing RNA-Seq-based repertoire profiling methods using targeted TCR-Seq as the gold standard. We also highlighted scenarios under which the RNA-Seq approach is suitable and can provide comparable accuracy to the TCR-Seq approach. Our results show that RNA-Seq-based methods are able to effectively capture the clonotypes and estimate the diversity of TCR repertoires, as well as to provide relative frequencies of clonotypes in T cell rich tissues and monoclonal repertoires. However, RNA-Seq-based TCR profiling methods have limited power in T cell poor tissues, especially in polyclonal repertoires of T cell poor tissues. The results of our benchmarking provide an additional appealing argument to incorporate the RNA-Seq into immune repertoire screening of cancer patients as it offers broader knowledge into the transcriptomic changes that exceed the limited information provided by TCR-Seq.